Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries

• Main Authors: Andrew E. Moran (Author), Margaret Farrell (Author), Danielle Cazabon (Author), Swagata Kumar Sahoo (Author), Doris Mugrditchian (Author), Anirudh Pidugu (Author), Carlos Chivardi (Author), Magdalena Walbaum (Author), Senait Alemayehu (Author), Wanrudee Isaranuwatchai (Author), Chaisiri Ankurawaranon (Author), Sohel R. Choudhury (Author), Sarah J. Pickersgill (Author), David A. Watkins (Author), Muhammad Jami Husain (Author), Krishna D. Rao (Author), Kunihiro Matsushita (Author), Matti Marklund (Author), Brian Hutchinson (Author), Rachel Nugent (Author), Deliana Kostova (Author), Renu Garg (Author)
• Format: Book
• Published: Pan American Health Organization, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Generally, hypertension control programs are cost-effective, including in low- and middle-income countries, but country governments and civil society are not likely to support hypertension control programs unless value is demonstrated in terms of public health benefits, budget impact, and value-for-...